Teva Gets Nod For $24M Nexium Pay-For-Delay Settlement
By Matthew Bultman ( June 12, 2015, 3:37 PM EDT) -- A Massachusetts federal judge on Friday gave tentative approval to a $24 million settlement between Teva Pharmaceutical Industries Ltd. and class action plaintiffs in a pay-for-delay case over generic versions of AstraZeneca PLC's heartburn drug Nexium....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.